Warnock, D. G., Thomas, C. P., Vujkovac, B., Campbell, R. C., Charrow, J., Laney, D. A., . . . Wanner, C. (2015). Antiproteinuric therapy and Fabry nephropathy: Factors associated with preserved kidney function during agalsidase-beta therapy. J Med Genet.
Chicago Style citaatWarnock, David G., Christie P. Thomas, Bojan Vujkovac, Ruth C. Campbell, Joel Charrow, Dawn A. Laney, Leslie L. Jackson, William R. Wilcox, en Christoph Wanner. "Antiproteinuric Therapy and Fabry Nephropathy: Factors Associated With Preserved Kidney Function During Agalsidase-beta Therapy." J Med Genet 2015.
MLA citatieWarnock, David G., et al. "Antiproteinuric Therapy and Fabry Nephropathy: Factors Associated With Preserved Kidney Function During Agalsidase-beta Therapy." J Med Genet 2015.